EBS
Price
$6.33
Change
-$0.08 (-1.25%)
Updated
Jun 4 closing price
Capitalization
120.07M
68 days until earnings call
RMTI
Price
$1.01
Change
-$0.00 (-0.00%)
Updated
Jun 4 closing price
Capitalization
49.87M
74 days until earnings call
Interact to see
Advertisement

EBS vs RMTI

Header iconEBS vs RMTI Comparison
Open Charts EBS vs RMTIBanner chart's image
Emergent Biosolutions
Price$6.33
Change-$0.08 (-1.25%)
Volume$722.03K
Capitalization120.07M
Rockwell Medical
Price$1.01
Change-$0.00 (-0.00%)
Volume$97.14K
Capitalization49.87M
EBS vs RMTI Comparison Chart
Loading...
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EBS vs. RMTI commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBS is a StrongBuy and RMTI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (EBS: $6.33 vs. RMTI: $1.01)
Brand notoriety: EBS and RMTI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EBS: 58% vs. RMTI: 44%
Market capitalization -- EBS: $120.07M vs. RMTI: $49.87M
EBS [@Pharmaceuticals: Other] is valued at $120.07M. RMTI’s [@Pharmaceuticals: Other] market capitalization is $49.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EBS’s FA Score shows that 1 FA rating(s) are green whileRMTI’s FA Score has 0 green FA rating(s).

  • EBS’s FA Score: 1 green, 4 red.
  • RMTI’s FA Score: 0 green, 5 red.
According to our system of comparison, EBS is a better buy in the long-term than RMTI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EBS’s TA Score shows that 5 TA indicator(s) are bullish while RMTI’s TA Score has 3 bullish TA indicator(s).

  • EBS’s TA Score: 5 bullish, 5 bearish.
  • RMTI’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, EBS is a better buy in the short-term than RMTI.

Price Growth

EBS (@Pharmaceuticals: Other) experienced а -2.62% price change this week, while RMTI (@Pharmaceuticals: Other) price change was +4.91% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +73.69%. For the same industry, the average monthly price growth was +15.08%, and the average quarterly price growth was +62.67%.

Reported Earning Dates

EBS is expected to report earnings on Aug 12, 2025.

RMTI is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+73.69% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EBS($120M) has a higher market cap than RMTI($49.9M). EBS YTD gains are higher at: -33.787 vs. RMTI (-50.490). RMTI has higher annual earnings (EBITDA): -4.69M vs. EBS (-518.2M). EBS has more cash in the bank: 112M vs. RMTI (10.9M). RMTI has less debt than EBS: RMTI (13.4M) vs EBS (860M). EBS has higher revenues than RMTI: EBS (1.02B) vs RMTI (83.6M).
EBSRMTIEBS / RMTI
Capitalization120M49.9M240%
EBITDA-518.2M-4.69M11,040%
Gain YTD-33.787-50.49067%
P/E Ratio17.73N/A-
Revenue1.02B83.6M1,224%
Total Cash112M10.9M1,028%
Total Debt860M13.4M6,418%
FUNDAMENTALS RATINGS
EBS vs RMTI: Fundamental Ratings
EBS
RMTI
OUTLOOK RATING
1..100
6910
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9490
PRICE GROWTH RATING
1..100
4693
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
65n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMTI's Valuation (42) in the Medical Specialties industry is in the same range as EBS (55) in the Biotechnology industry. This means that RMTI’s stock grew similarly to EBS’s over the last 12 months.

RMTI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as EBS (100) in the Biotechnology industry. This means that RMTI’s stock grew similarly to EBS’s over the last 12 months.

RMTI's SMR Rating (90) in the Medical Specialties industry is in the same range as EBS (94) in the Biotechnology industry. This means that RMTI’s stock grew similarly to EBS’s over the last 12 months.

EBS's Price Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for RMTI (93) in the Medical Specialties industry. This means that EBS’s stock grew somewhat faster than RMTI’s over the last 12 months.

EBS's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for RMTI (100) in the Medical Specialties industry. This means that EBS’s stock grew significantly faster than RMTI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EBSRMTI
RSI
ODDS (%)
Bearish Trend 1 day ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 16 days ago
76%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
EBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RMTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NOC491.293.07
+0.63%
Northrop Grumman Corp
BCC87.54-0.06
-0.07%
Boise Cascade Company
GP0.42N/A
-0.71%
GreenPower Motor Company
AMRN11.85-0.11
-0.88%
Amarin Corp Plc
SCS10.37-0.15
-1.43%
Steelcase

RMTI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RMTI has been loosely correlated with AVDL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if RMTI jumps, then AVDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RMTI
1D Price
Change %
RMTI100%
N/A
AVDL - RMTI
34%
Loosely correlated
-1.27%
HROW - RMTI
30%
Poorly correlated
+0.58%
SNDL - RMTI
29%
Poorly correlated
+0.78%
OPTN - RMTI
28%
Poorly correlated
N/A
EBS - RMTI
26%
Poorly correlated
-1.25%
More